Xtx Topco LTD Pro Qr Therapeutics N.V. Transaction History

Xtx Topco LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.62 - $2.32 $10,116 - $14,488	6,245 Added 61.47%	16,405 $26,000
Q1 2023 May 12, 2023	BUY	$1.99 - $3.66 $20,218 - $37,185	10,160 New	10,160 $21,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.0 $117,928 - $210,587	-210,587 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.9 - $8.39 $189,528 - $1.77 Million	210,587 New	210,587 $191,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $191M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.